Price T Rowe Associates Inc Legend Biotech Corp Put Options Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding LEGN
# of Institutions
232Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$257 Million3.96% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$205 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$196 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$195 Million0.86% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.5MShares$120 Million4.74% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.72B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...